Haleon plc (HLN) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
HLN Revenue Growth
Revenue Breakdown (FY 2022)
HLN's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
By Geography
HLN Revenue Analysis (2019–2025)
As of May 8, 2026, Haleon plc (HLN) generated trailing twelve-month (TTM) revenue of $22.23 billion, reflecting slight decline in growth of -0.4% year-over-year. The most recent quarter (Q4 2025) recorded $5.52 billion in revenue, up 0.7% sequentially.
Looking at the longer-term picture, HLN's 5-year compound annual growth rate (CAGR) stands at +1.7%, indicating moderate growth over time. The company achieved its highest annual revenue of $11.30 billion in 2023.
Revenue diversification analysis shows HLN's business is primarily driven by Respiratory Health (100%). With over half of revenue concentrated in Respiratory Health, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including KVUE (-0.1% YoY), CHD (+2.2% YoY), and PG (+3.3% YoY), HLN has underperformed the peer group in terms of revenue growth. Compare HLN vs KVUE →
HLN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HLNCurrent | $22.2B | -0.4% | +1.7% | 22.4% | |
 KVUE | $15.1B | -0.1% | +0.9% | 17.9% | |
 CHD | $6.2B | +2.2% | +4.8% | 17.4% | |
 PG | $84.3B | +3.3% | +3.5% | 24.3% | |
 CL | $20.4B | +1.4% | +4.4% | 21.3% | |
 PBH | $1.1B | -1.3% | +3.4% | 29.6% |
HLN Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $10.79B | -4.0% | $6.99B | 64.8% | $2.42B | 22.4% |
| 2024 | $11.23B | -0.6% | $6.95B | 61.9% | $2.21B | 19.6% |
| 2023 | $11.30B | +4.1% | $6.96B | 61.6% | $2.00B | 17.7% |
| 2022 | $10.86B | +13.8% | $6.58B | 60.6% | $1.82B | 16.8% |
| 2021 | $9.54B | -3.5% | $5.95B | 62.3% | $1.64B | 17.2% |
| 2020 | $9.89B | +16.7% | $5.91B | 59.7% | $1.60B | 16.2% |
| 2019 | $8.48B | - | $4.80B | 56.6% | $897.0M | 10.6% |
Full HLN Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See HLN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HLN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HLN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHLN — Frequently Asked Questions
Quick answers to the most common questions about buying HLN stock.
Is HLN's revenue growth accelerating or slowing?
HLN revenue growth slowed to -0.4%, below the 5-year CAGR of +1.7%. TTM revenue is $22.2B. The deceleration marks a shift from historical growth rates.
What is HLN's long-term revenue growth rate?
Haleon plc's 5-year revenue CAGR of +1.7% reflects the variable expansion pattern. Current YoY growth of -0.4% is near this long-term average.
How is HLN's revenue distributed by segment?
HLN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.